Clinical pharmacokinetics of oxaliplatin: a critical review.

奥沙利铂 药代动力学 医学 肾功能 铂金 肾脏生理学 排泄 白蛋白 间隙 血液蛋白质类 结直肠癌 内科学 药理学 泌尿科 内分泌学 癌症 化学 生物化学 催化作用
作者
Martin A. Graham,G. Lockwood,Dennis Greenslade,S. Brienza,M. Bayssas,Érick Gamelin
出处
期刊:PubMed 卷期号:6 (4): 1205-18 被引量:447
链接
标识
摘要

Oxaliplatin (cis-[(1R,2R)-1,2-cyclohexanediamine-N,N'] oxalato(2-)-O,O'] platinum; Eloxatine) is a novel platinum coordination complex used for the treatment of metastatic colorectal carcinoma in combination with fluoropyrimidines. The objective of this review is to integrate the key data from multiple studies into a single, comprehensive overview of oxaliplatin disposition in cancer patients. The pharmacokinetics (PKs) of unbound platinum in plasma ultrafiltrate after oxaliplatin administration was triphasic, characterized by a short initial distribution phase and a long terminal elimination phase (t1/2, 252-273 h). No accumulation was observed in plasma ultrafiltrate after 130 mg/m2 every 3 weeks or 85 mg/m2 every 2 weeks. Interpatient and intrapatient variability in platinum exposure (area under the curve(0-48)) is moderate to low (33 and 5% respectively). In the blood, platinum binds irreversibly to plasma proteins (predominantly serum albumin) and erythrocytes. Accumulation of platinum in blood cells is not considered to be clinically significant. Platinum is rapidly cleared from plasma by covalent binding to tissues and renal elimination. Urinary excretion (53.8 +/- 9.1%) was the predominant route of platinum elimination, with fecal excretion accounting for only 2.1 +/- 1.9% of the administered dose 5 days postadministration. Tissue binding and renal elimination contribute equally to the clearance of ultrafilterable platinum from plasma. Renal clearance of platinum significantly correlated with glomerular filtration rate, indicating that glomerular filtration is the principal mechanism of platinum elimination by the kidneys. Clearance of ultrafilterable platinum is lower in patients with moderate renal impairment; however, no marked increase in drug toxicity was reported. The effect of severe renal impairment on platinum clearance and toxicity is currently unknown. Covariates such as age, sex, and hepatic impairment had no significant effect on the clearance of ultrafilterable platinum, and dose adjustment due to these variables is not required. Oxaliplatin undergoes rapid and extensive nonenzymatic biotransformation and is not subjected to CYP450-mediated metabolism. Up to 17 platinum-containing products have been observed in plasma ultrafiltrate samples from patients. These include several proximate cytotoxic species, including the monochloro-, dichloro-, and diaquo-diaminocyclohexane platinum complexes, along with several other noncytotoxic products. Oxaliplatin does not inhibit CYP450 isoenzymes in vitro. Platinum was not displaced from plasma proteins by a variety of concomitant medications tested in vitro, and no marked PK interactions between oxaliplatin, 5-fluorouracil, and irinothecan have been observed. These results indicate that the additive/synergistic antitumor activity observed with these agents is not due to major alterations in drug exposure, and the enhanced efficacy is likely to be mechanistically based. Together, these PK, biotransformation, drug-drug interaction analyses and studies in special patient populations provide a firm scientific basis for the safe and effective use of oxaliplatin in the clinic. These analyses also reveal that the pharmacological activity of oxaliplatin may be attributable, at least in part, to the unique pattern of platinum disposition observed in patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机智灵薇完成签到,获得积分10
2秒前
GERRARD完成签到,获得积分10
2秒前
笨笨以莲发布了新的文献求助20
5秒前
小广完成签到,获得积分10
5秒前
田様应助大橙子采纳,获得10
8秒前
8秒前
SYLH应助Echo_1995采纳,获得10
10秒前
吕小布完成签到,获得积分10
11秒前
骑驴追火箭完成签到,获得积分10
13秒前
baomingqiu完成签到 ,获得积分10
13秒前
乐观寻雪完成签到 ,获得积分10
15秒前
量子星尘发布了新的文献求助10
16秒前
复杂勒完成签到,获得积分10
16秒前
17秒前
bird完成签到,获得积分10
18秒前
AaronDP发布了新的文献求助50
19秒前
terryok完成签到,获得积分10
20秒前
Cll完成签到 ,获得积分10
20秒前
聪明的宛菡完成签到,获得积分10
21秒前
CNYDNZB完成签到 ,获得积分10
21秒前
xxj完成签到 ,获得积分10
21秒前
芊芊完成签到 ,获得积分10
22秒前
yar应助bluesky采纳,获得10
22秒前
海人完成签到 ,获得积分10
23秒前
SY15732023811完成签到 ,获得积分10
25秒前
李建勋完成签到,获得积分10
25秒前
科研通AI2S应助一路芬芳采纳,获得10
25秒前
黄花完成签到 ,获得积分10
26秒前
刘珍荣完成签到,获得积分10
27秒前
27秒前
紫金之巅完成签到 ,获得积分10
27秒前
Gang完成签到,获得积分10
28秒前
29秒前
29秒前
30秒前
CYYDNDB完成签到 ,获得积分10
30秒前
粿粿一定行完成签到 ,获得积分10
31秒前
32秒前
战战完成签到,获得积分10
33秒前
xlk2222完成签到,获得积分10
36秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022